Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare
- 18 February 2021
- journal article
- editorial
- Published by American Association for Cancer Research (AACR) in Blood Cancer Discovery
- Vol. 2 (2), 119-124
- https://doi.org/10.1158/2643-3230.bcd-20-0123
Abstract
African Americans are at higher risk of multiple myeloma (MM) yet are underrepresented in clinical trials and reap fewer benefits from novel therapies of the disease. To improve representation of African Americans in MM clinical trials, researchers, healthcare providers, patients, industry partners, and regulators at an FDA–AACR workshop developed recommendations to all stakeholders. The outlined principles offer a road map to addressing disparities broadly in clinical trials.Keywords
This publication has 11 references indexed in Scilit:
- Closing the Rural Cancer Care Gap: Three Institutional ApproachesJCO Oncology Practice, 2020
- Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical CompaniesJNCI Cancer Spectrum, 2020
- With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA StudyBlood, 2019
- Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysisBlood Advances, 2019
- Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018JAMA Oncology, 2019
- The New FDA Real-World Evidence Program to Support Development of Drugs and BiologicsJournal of Diabetes Science and Technology, 2019
- Cancer statistics for African Americans, 2019CA: A Cancer Journal for Clinicians, 2019
- Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestryBlood Cancer Journal, 2018
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patientsLeukemia, 2013
- Racial disparities in incidence and outcome in multiple myeloma: a population-based studyBlood, 2010